Photo by lamoune from unsplash
Paxlovid (nirmatrelvir/ritonavir) is an oral antiviral combination for the treatment of COVID‐19 in adults at risk of progression to severe disease. This article summarises its indications, interactions and efficacy. Click to show full abstract
Paxlovid (nirmatrelvir/ritonavir) is an oral antiviral combination for the treatment of COVID‐19 in adults at risk of progression to severe disease. This article summarises its indications, interactions and efficacy.
Keywords:
treatment covid;
antiviral combination;
combination treatment
Journal Title: Prescriber
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Prescriber
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!